Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > QuantuMDx announce prototype handheld lab for 15 minute malaria diagnosis and drug resistance testing

CEO Elaine Warburton OBE shows QuantuMDx's first prototype disposable handheld malaria diagnostic and drug resistance lab to Maire Geoghegan-Quinn, EU Commissioner for Research, Innovation & Science at the EU Innovation Conference ©EC/CE
CEO Elaine Warburton OBE shows QuantuMDx's first prototype disposable handheld malaria diagnostic and drug resistance lab to Maire Geoghegan-Quinn, EU Commissioner for Research, Innovation & Science at the EU Innovation Conference ©EC/CE

Abstract:
This World Malaria Day, British biotech QuantuMDx announces the first prototype of their pioneering disposable handheld lab for 15 minute malaria diagnosis and drug resistance testing. A low cost disposable cartridge is inserted into QuantuMDx's universal reader Q-POC™ to provide testing for a few dollars at the patient's side.

QuantuMDx announce prototype handheld lab for 15 minute malaria diagnosis and drug resistance testing

Newcastle, UK | Posted on April 23rd, 2014

Rapid drug resistance testing will enable frontline healthworkers to prescribe the right drug, first time. QuantuMDx anticipates that this device will help to stem the rising tide of drug resistance by providing affordable and accurate testing for the estimated 200 million people who contract malaria each year, and maybe even play a supporting role in malaria elimination.

QuantuMDx's diagnostic technology is being harnessed to tackle malaria by the European Union FP7 funded NanoMal consortium led by St George's, University of London. This prototype brings the consortium one step closer to clinical trials, expected later this year in Gabon. These trials will benefit from the expertise of consortium partners Universitat Tubingen and the Karolinska Institutet.

As the World Health Organization (WHO) urges donors, organizations and institutions worldwide to "Invest in the Future" to defeat malaria, QuantuMDx utilized a novel approach to gather additional funds for their upcoming clinical trial. An Indiegogo campaign crowdfunded over $18,000 for the further development and production of assays for the trial.

Jonathan O'Halloran, co-founder and CSO said "After six years of development, it is rewarding to finally hold in my hand a prototype of our disposable test cartridge. This device represents a significant piece in the puzzle for my vision of a global network- an infectious disease monitoring system, wherein GPS data and real-time DNA sequence data are immediately analysed and used to track emerging new infectious disease threats and drug resistance.

Starting with malaria, this system will benefit not just the patient but also epidemiologists and public health officials, as real-time identification of novel pathogens and drug resistance mutations will allow for the mobilization of resources including the correct anti-infective to the exact site that these diseases originate. This will be significantly faster than relying on traditional methods of identifying & monitoring these diseases."

####

About QuantuMDx Group
QuantuMDx Group is one of the most exciting biotechs to emerge from the UK. Their robust handheld laboratory, which reads and sequences DNA and converts it into binary code using a tiny computer chip, is ideally suited to help address the humanitarian health burden by offering molecular diagnostics at a fraction of the price of traditional testing.

Rapidly & accurately detecting and monitoring emerging drug resistance of infectious diseases such as malaria, TB and HIV will enable health professionals to immediately prescribe the most effective drug against that disease. Once the device has passed regulatory approval, it will be available in developed countries for infectious disease testing and rapid cancer profiling and, in time, be available over-the-counter at pharmacies.

Headquartered at The International Centre for Life in Newcastle, UK with subsidiaries in the USA (Chattanooga) and Asia (A*Star’s Genome Institute of Singapore), QuantuMDx was co-founded by Elaine Warburton, inventor and CSO Jonathan O’Halloran and CFO Julian Warburton. Fellow Board members include CMO Professor Sir John Burn, COO Dr Sam Whitehouse and President of QuantuMDx USA Paul Fitzpatrick. Prof Sanjeev Krishna chairs the Infectious Disease Advisory Committee.

QuantuMDx has received numerous awards for innovation and is the recipient of a number of large grants from The UK’s Technology Strategy Board (TB diagnostic), The Biomedical Catalyst Fund (tumour profiler), NHS NIHR’s Invention for Innovation Program (DNA sequencer) and the European Union (“NanoMal” malaria diagnostic).

For more information, please click here

Contacts:
United Kingdom:
Market Keeper's House
International Centre for Life
Times Square
Newcastle, NE1 4EP, UK

Singapore:
16 Raffles Quay
#33-03, Hong Leong Building
Singapore 048581

USA:
25 E. Main Street, Suite 205
Chattanooga, TN 37408

Copyright © QuantuMDx Group

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

When mediated by superconductivity, light pushes matter million times more April 28th, 2015

Chemists strike nano-gold: 4 new atomic structures for gold nanoparticle clusters: Research builds upon work by Nobel Prize-winning team from Stanford University April 28th, 2015

More is less in novel electronic material: Adding electrons actually shrinks the system April 27th, 2015

Two-dimensional semiconductor comes clean April 27th, 2015

Products

Iran Unveils 6 Knowledge-Based Products April 11th, 2015

Toronto-based Environmental Technology Pioneer Green Earth Nano Science Expands in EU February 6th, 2015

DELSEY by Philippe Starck DELSEY Launches New Collection by Philippe Starck February 4th, 2015

NEI introduces NANOMYTE® SuperAi, a Durable Anti-ice Coating December 4th, 2014

Nanomedicine

Chemists strike nano-gold: 4 new atomic structures for gold nanoparticle clusters: Research builds upon work by Nobel Prize-winning team from Stanford University April 28th, 2015

Self-assembling biomaterial forms nanostructure templates for human tissue formation April 27th, 2015

International research team discovers new mechanism behind malaria progression: Findings provide a new avenue for research in malaria treatment April 27th, 2015

Scientists join forces to reveal the mass and shape of single molecules April 27th, 2015

Announcements

When mediated by superconductivity, light pushes matter million times more April 28th, 2015

Chemists strike nano-gold: 4 new atomic structures for gold nanoparticle clusters: Research builds upon work by Nobel Prize-winning team from Stanford University April 28th, 2015

Graphenea celebrates fifth anniversary April 27th, 2015

Sensor Designed in Iran Able to Remove Formaldehyde Gas from Environment April 27th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project